Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers

Dig Dis Sci. 2010 Feb;55(2):268-75. doi: 10.1007/s10620-009-0732-5. Epub 2009 Feb 25.

Abstract

Background/aims: The aims of the present study were to elucidate whether oxidative stress has a role in Con A-induced hepatitis and to examine if antioxidants may protect against liver damage in this model.

Methods: Hepatitis was induced in Balb/c mice by administration of Con A (18 mg/kg) to the tail vein. Liver enzymes and histology were determined 24 h after Con A injection. Tumor necrosis factor alpha (TNFalpha) and interleukin-10 (IL-10) levels were assayed 2 h after Con A injection. Hepatic malondialdehyde levels were measured at 1, 3, 8, 12, 18, and 24 h after Con A injection in order to examine the timing of free-radicals formation. Nuclear factor kappa B (NF-kappabeta) activation was determined by electrophoresis mobility shift assay (EMSA) 1 and 2 h after Con A injection. In separate experiments, mice were pretreated with either dimethylsulfoxide or dimethylthiourea before Con A inoculation. The antioxidant and NF-kappabeta inhibitor pyrrolidine dithiocarbamate (PDTC) was used as positive control.

Results: Hepatic malondialdehyde levels increased 12, 18, and 24 h after Con A inoculation but not earlier. Serum levels of liver enzymes and TNFalpha, hepatic malondialdehyde, and protein carbonyls and the histologic necroinflammatory score were significantly reduced in the antioxidants-treated mice, while IL-10 levels were increased. Dimethylsulfoxide, dimethylthiourea, and PDTC inhibited oxidative stress, but only PDTC inhibited Con A-induced NF-kappaB activation.

Conclusions: Reactive oxygen species play a role in immune-mediated Con A-induced hepatitis probably secondary to immune-mediated liver damage. Scavenging of reactive oxygen species by antioxidants prevents hepatitis independently of NF-kappaB inhibition and may be a new therapeutic target in this experimental model.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Chemical and Drug Induced Liver Injury / prevention & control*
  • Concanavalin A / toxicity*
  • Dimethyl Sulfoxide / therapeutic use
  • Disease Models, Animal
  • Electrophoretic Mobility Shift Assay
  • Enzyme-Linked Immunosorbent Assay
  • Free Radical Scavengers / therapeutic use*
  • Interleukin-10 / blood
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Malondialdehyde / metabolism
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B / drug effects
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • Proline / analogs & derivatives
  • Proline / therapeutic use
  • Thiocarbamates / therapeutic use
  • Thiourea / analogs & derivatives
  • Thiourea / therapeutic use
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Antioxidants
  • Free Radical Scavengers
  • NF-kappa B
  • Thiocarbamates
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Interleukin-10
  • prolinedithiocarbamate
  • Malondialdehyde
  • 1,3-dimethylthiourea
  • Proline
  • Thiourea
  • Dimethyl Sulfoxide